Spin and bias: The tip of the iceberg

Annals of Oncology

Volumn 24, Issue 7, 2013, Pages 1949-1950

  Vera Badillo, F E ^a   Tannock, I F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; EXPERIMENTAL THERAPY; INFORMATION PROCESSING; LETTER; MEDICAL DECISION MAKING; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC ERROR; TOXICITY; TREATMENT FAILURE; TREATMENT OUTCOME; BIOASSAY; BREAST NEOPLASMS; FEMALE; HUMAN; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); BREAST TUMOR; NOTE;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; ENDPOINT DETERMINATION; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84883748585     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt211     Document Type: Letter

References (1)

1. Vera-Badillo FE, Shapiro R, Ocana A et al. Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer. Ann Oncol 2013; 24: 1238-1244.